Amarin Corporation plc Message Board
-
basically officially selling stock company
-
Pfizer could buy DNND before European approval as $7Billions are set aside for Pfizer after Pfizer is in partnership with Athersys Inc, MultiStem is also in a Phase II trial, separate from Pfizer, for treating people suffering from moderate to moderately severe strokes.
-
5 th June AAFYQ
-
◦ Presented data at AUA that further analyzed Phase III IMPACT data to identify prognostic variables that may support early administration of PROVENGE after diagnosis of metastatic castrate resistant prostate cancer
◦Actively evaluating partnering strategies for European expansion; continuing to enroll patients in the sipuleucel-T European Union open-label study; expect a regulatory decision in Europe in the second half of 2013
◦ Completed enrollment of PROVENGE and ADT sequencing study; presented initial data at ASCO-GU and expect to present additional data in 2013
◦ Completed enrollment of PROVENGE and Zytiga®(abiraterone) sequencing study; presented initial data at ASCO-GU and expect to present additional data in 2013
◦ Supporting 19 novel investigator initiated trials (IITs) to advance understanding of immunotherapy and the treatment of advanced prostate cancer
◦ Named steering committee for Phase II trial for sequencing PROVENGE with Xtandi® (enzalutamide) and expect to begin enrolling patients in the fourth quarter of 2013 - Reply to
IT WENT UP TO $1.95 FOR A REASON! HISTORY TELLS ME SOMETING'S UP! I MISSED THE SAME SIGNALS WITH SPRINT, CLWR, AMD, BSX, SVU RECENTLY,
by admshafa •May 10, 2013 11:45 AMIts obvious that Institution holding wants to unload and this is what they do - Take it high so that people keep buying thinking it went all that high ...and then comes pennies status. GLTA
-
Before that collaboration might work out - either NOVARTIS or Bristol Mayer Squibb
-
Why you shift now to wallstreet ..
-
Remember no short is allowed on DNDN
-
DNDN !
-
European joint venture might be with NOVARTIS as some discussion before and that has happen this month.
-
-
-
Sit back see the ride...
-
did u hear that
-
I told you price drop with only 6 million - Apex Invest Fund invested 121Million on this
-
4.33 would be sure but howfar EU factor will play -MMS will decide.
-
Do not be sentimental with earning call - EU approval & Collaboration around corner.
-
-
CHMP considered Provange approval Agenda this month
-
AFFY & DNDN both were victim of oversold & short sell.